Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 20/20 | 0.52 |
| ▸ | SSTR1 | P30872 | 5/20 | 0.52 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.42 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.42 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24057356 | 1.00 | SSTR4 (0.52) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL24047659 | 0.88 | SSTR4 (0.67) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL24048369 | 0.88 | SSTR4 (0.67) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| Formic Acid SCHEMBL30449133 | 0.85 | SSTR4 (0.62) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL25735300 | 0.83 | SSTR4 (0.44) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL24048320 | 0.83 | SSTR4 (0.65) | SSTR4SSTR1SSTR2SSTR3SSTR5 | |
| SCHEMBL25233504 | 0.81 | SSTR4 (0.76) | SSTR4SSTR1 | |
| SCHEMBL30023497 | 0.81 | SSTR4 (0.76) | SSTR4SSTR1 | |
| SCHEMBL24057990 | 0.81 | SSTR4 (0.76) | SSTR4SSTR1 | |
| SCHEMBL25276190 | 0.81 | SSTR4 (0.76) | SSTR4SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192683-A1 | FUSED RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | GUANGZHOU FERMION TECHNOLOGY CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192683-A1 | FUSED RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | SSTR4, SSTR3, NPY4R | SSTR4 1/4885SSTR1 4/4885SSTR2 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.